Process analytical technologies in the pharmaceutical industry : the FDA's PAT initiative : Process analytical chemistryHINZ, Dirk C.Analytical and bioanalytical chemistry. 2006, Vol 384, Num 5, pp 1036-1042, 7 p.Article

The American Society for Clinical Pharmacology and Therapeutics and the pharmaceutical industryABRAMS, W. B.Clinical pharmacology and therapeutics. 1990, Vol 47, Num 2, pp 282-286, issn 0009-9236Article

Networks of innovation or networks of opportunity? The making of the Spanish antibiotics industryPUIG, Nuria.Ambix. 2004, Vol 51, Num 2, pp 167-185, issn 0002-6980, 19 p.Article

Failings of the pharmaceutical industryMEDAWAR, C.Pharmaceutical medicine (Basingstoke). 1987, Vol 2, Num 3, pp 259-263, issn 0265-0673Article

Les ambitions d'Ingérop dans l'ingénierie pharmaceutique : Pharmacie = Ingerop's ambitions in pharmaceutical engineeringSAVOSTIANOFF, Dmitri.Info chimie magazine. 2000, Num 423, pp 102-103, issn 1286-0921Article

Industrie pharmaceutique: logistique de distributionGOETZ-LOPES, Virginie.Techniques de l'ingénieur. L'Entreprise industrielle. 2007, Vol AGL1, Num AG5435, issn 1282-9072, AG5435.1-AG5435.18Article

Results from a bench marking survey on cassette dosing practices in the pharmaceutical industryACKERMANN, Bradley L.Journal of the American Society for Mass Spectrometry. 2004, Vol 15, Num 9, pp 1374-1377, issn 1044-0305, 4 p.Article

Logistik und Verfahrenstechnik in der Fabrik 2000 = Logistics and process technology in the factory of the year 2000FINK, M; SIMON, R. W.Pharmazeutische Industrie. 1995, Vol 57, Num 6, pp 507-509, issn 0031-711X, 3 p.Article

Having the last laugh at big pharmaCOOMBES, Rebecca.BMJ. British medical journal (International ed.). 2007, Vol 334, Num 7590, pp 396-397, issn 0959-8146, 2 p.Article

Upping the ante on antibodies : Antibody engineering and manufactureBAKER, Monya.Nature biotechnology. 2005, Vol 23, Num 9, pp 1065-1072, issn 1087-0156, 8 p.Article

Stratégies de diversification dans le secteur biopharmaceutiqueLE, Philippe; HARA, Liuichi; GANESAN, Balaji et al.Biofutur (Puteaux). 2011, Num 326, pp 60-62, issn 0294-3506, 3 p.Article

Ghosts in the Machine: Comment on SismondoMCHENRY, Leemon.Social studies of science. 2009, Vol 39, Num 6, pp 943-947, issn 0306-3127, 5 p.Article

Industrie pharmaceutique: logistique de distribution. ApplicationsGOETZ-LOPES, Virginie.Techniques de l'ingénieur. L'Entreprise industrielle. 2008, Vol AGL1, Num AG5436, issn 1282-9072, AG5436.1-AG5436.10Article

L'échantillonnage dans le contrôle de fabrication des médicamentsKIGER, J.L.LA LETTRE DES NOUVELLES PHARMACEUTIQUES : BULLETIN DE L'ORDRE DES PHARMACIENS. 1981, Num 242, pp 269-384Article

Littérature et industrie pharmaceutique : je t'aime moi non plusBENKIMOUN, P.Littérature et santé. SEVE : LES TRIBUNES DE LA SANTE. 2009, Num 23, pp 51-58, 8 p.Book Chapter

Getting real about valuations in biotechVILLIGER, Ralph; BOGDAN, Boris.Nature biotechnology. 2005, Vol 23, Num 4, pp 423-428, issn 1087-0156, 6 p.Article

Blood brothers : alliances between biotechnology and pharmaceutical companies in the U.SDIBNER, M. D.Bio/technology (New York, N.Y. 1983). 1993, Vol 11, Num 10, pp 1120-1123, issn 0733-222X, 3 p.Article

Le droit pénal de la pharmacieAZEMA, J.1978, 218 p., isbn 2-711-10075-8Book

What's fueling the biotech engine—2011 to 2012AGGARWAL, Saurabh (rob).Nature biotechnology (Print). 2012, Vol 30, Num 12, pp 1191-1197, issn 1087-0156, 7 p.Article

Ghosts in the Machine: Reply to McHenry (2009)SISMONDO, Sergio.Social studies of science. 2009, Vol 39, Num 6, pp 949-952, issn 0306-3127, 4 p.Article

Consolidated alliances : how biotechnology and pharmaceutical companies are finding ways to prosper togetherLYONS, P. D; LANG, J; GUZZO, M. A et al.Bio/technology (New York, N.Y. 1983). 1993, Vol 11, Num 13, pp 1529-1532, issn 0733-222XArticle

Fortschritte auf dem Gebiet der Arzneimittelentwicklung. XIX = Progrès dans la recherche pharmaceutique. XIX = Progress in the field of drug development XIXDELENK-HEYDENREICH, K; HENKLER, G; KELLER, U et al.Pharmazie. 1986, Vol 41, Num 9, pp 617-626, issn 0031-7144Article

HOW A MARRIAGE WITH BIG PHARMA ENDED IN DIVORCEARIE, Sophie.BMJ (Overseas and retired doctors ed.). 2013, Vol 347, Num 7928, pp 15-16, issn 1759-2151, 2 p.Article

New Product Development with Discrete Event Simulation: Application to Portfolio Management for the Pharmaceutical IndustryPEREZ-ESCOBEDO, J. L; AZZARO-PANTEL, C; PIBOULEAU, L et al.Industrial & engineering chemistry research. 2011, Vol 50, Num 18, pp 10615-10629, issn 0888-5885, 15 p.Article

Tautomer Preference in PDB Complexes and its Impact on Structure-Based Drug DiscoveryMILLETTI, Francesca; VULPETTI, Anna.Journal of chemical information and modeling. 2010, Vol 50, Num 6, pp 1062-1074, issn 1549-9596, 13 p.Article